Ventricular pacing and myocardial function in patient with congenital heart block.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
10 2021
Historique:
revised: 12 07 2021
received: 21 05 2021
accepted: 16 07 2021
pubmed: 20 8 2021
medline: 21 10 2021
entrez: 19 8 2021
Statut: ppublish

Résumé

Pacing-induced cardiomyopathy (PICM) is a potential complication of chronic right ventricular (RV) pacing, but its characterization in adult patients is often complicated by pre-existing cardiomyopathy. This study investigated the incidence of PICM in patients with congenital heart block (cHB) who have conduction disease from birth without confounding pre-existing cardiac conditions. This retrospective cohort analysis included 42 patients with cHB and baseline left ventricular ejection fraction (LVEF) ≥50%. Kaplan-Meier analysis was used to assess freedom from cardiomyopathy (defined as LVEF <50%) between paced and nonpaced patients. Patients were 26 ± 3 years old at first presentation, 64% were women and baseline LVEF was 60.0 ± 0.2%. Median follow-up from birth was 35 (interquartile range [IQR]: 20-42) years with a median of 6.7 years (IQR: 3.6-9.2) at our institution. Thirty-two patients received pacing at mean age 21 ± 3 years. Patients receiving a pacemaker (PM) were significantly more likely to develop a cardiomyopathy (p = .021) and no patient developed a cardiomyopathy in the absence of a PM. Four patients who developed a new cardiomyopathy were upgraded to biventricular pacing, leading to stabilization or improvement of LVEF. In a relatively young and healthy cHB cohort, RV pacing is associated with a higher risk of developing a cardiomyopathy. These data confirm the deleterious effects of RV pacing on myocardial function in patients without pre-existing structural cardiac disease and has clinical implications to the management of patients with cHB.

Identifiants

pubmed: 34409682
doi: 10.1111/jce.15207
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2684-2689

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Merchant F, Mittal S. Pacing induced cardiomyopathy. J Cardiovasc Electrophysiol. 2020;31:286-292.
Khurshid S, Epstein AE, Verdino RJ, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Hear Rhythm. 2014;11:1619-1625.
Moore BM, Medi C, McGuire MA, Celermajer DS, Cordina RL. Pacing-associated cardiomyopathy in adult congenital heart disease. Open Hear. 2020;7:1-7.
Pruetz JD, Miller JC, Loeb GE, Silka MJ, Bar-Cohen Y, Chmait RH. Prenatal diagnosis and management of congenital complete heart block. Birth Defects Res. 2019;111:380-388.
Moak et al Barron KS, T Hougen J, Wiles HB, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. JACC. 2001;37:238-242.
Tantengco MV, Thomas RL, Karpawich PP. Left ventricular dysfunction after long-term right ventricular apical pacing in the young. JACC. 2001;37:2093-2100.
Cantinotti M, Scalese M, Murzi B, et al. Echocardiographic nomograms for chamber diameters and areas in caucasian children. J Am Soc Echocardiogr. 2014;27:1279-1292.
Lang RM, Badano LP, Mor-Avi V, et al. the American Society of Echocardiography Recommendations for Cardiac Chamber Quantification in Adults. J Am Soc Echocardiogr. 2015;28:1-39.
Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. JACC. 2019;74:e51-e156.
Cheung JW, Ip JE, Markowitz SM, et al. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: a comparative analysis using a United States National Database 2003-2013. Hear Rhythm. 2017;14:1043-1050.
Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. JACC. 2005;46:2277-2283.
Janousek J, Tomek V, Chaloupecky V, Gebauer RA. Dilated cardiomyopathy associated with dual-chamber pacing in infants: improvement through either left ventricular cardiac resynchronization or programming the pacemaker off allowing intrinsic normal conduction. J Cardiovasc Electrophysiol. 2004;15:470-474.
Lyon S, Dandamudi G, Kean A. Permanent His-bundle pacing in pediatrics and congenital heart disease. J Innov Card Rhythm Manag. 2020;11:4005-4012.
Manolis AA, Manolis T, Melita H, Manolis AS. Congenital heart block: pace earlier (Childhood) than later (Adulthood). Trends Cardiovasc Med. 2020;30:275-286.
Van Geldorp IE, Delhaas T, Gebauer RA, et al. Impact of the permanent ventricular pacing site on left ventricular function in children: a retrospective multicentre survey. Heart. 2011;97:2051-2055.

Auteurs

Gautam Rangavajla (G)

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Suresh Mulukutla (S)

Department of Medicine, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Floyd Thoma (F)

Department of Medicine, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Krishna Kancharla (K)

Department of Medicine, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Aditya Bhonsale (A)

Department of Medicine, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

N A Mark Estes (NAM)

Department of Medicine, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Sandeep K Jain (SK)

Department of Medicine, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Samir Saba (S)

Department of Medicine, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH